Your browser doesn't support javascript.
loading
IL-1/inhibitory κB kinase ε-induced glycolysis augment epithelial effector function and promote allergic airways disease.
Qian, Xi; Aboushousha, Reem; van de Wetering, Cheryl; Chia, Shi B; Amiel, Eyal; Schneider, Robert W; van der Velden, Jos L J; Lahue, Karolyn G; Hoagland, Daisy A; Casey, Dylan T; Daphtary, Nirav; Ather, Jennifer L; Randall, Matthew J; Aliyeva, Minara; Black, Kendall E; Chapman, David G; Lundblad, Lennart K A; McMillan, David H; Dixon, Anne E; Anathy, Vikas; Irvin, Charles G; Poynter, Matthew E; Wouters, Emiel F M; Vacek, Pamela M; Henket, Monique; Schleich, Florence; Louis, Renaud; van der Vliet, Albert; Janssen-Heininger, Yvonne M W.
Afiliação
  • Qian X; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Aboushousha R; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • van de Wetering C; Department of Pulmonology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Chia SB; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Amiel E; Department of Medical Laboratory and Radiation, University of Vermont College of Nursing and Health Sciences, Burlington, Vt.
  • Schneider RW; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • van der Velden JLJ; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Lahue KG; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Hoagland DA; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Casey DT; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Daphtary N; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Ather JL; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Randall MJ; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Aliyeva M; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Black KE; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Chapman DG; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt; Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Lundblad LKA; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • McMillan DH; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Dixon AE; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Anathy V; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Irvin CG; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Poynter ME; Department of Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Wouters EFM; Department of Pulmonology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Vacek PM; Medical Biostatistics Unit, University of Vermont College of Medicine, Burlington, Vt.
  • Henket M; Department of Respiratory Medicine, CHU Sart-TilmanB35, Liege, Belgium.
  • Schleich F; Department of Respiratory Medicine, CHU Sart-TilmanB35, Liege, Belgium.
  • Louis R; Department of Respiratory Medicine, CHU Sart-TilmanB35, Liege, Belgium.
  • van der Vliet A; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
  • Janssen-Heininger YMW; Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt. Electronic address: yvonne.janssen@uvm.edu.
J Allergy Clin Immunol ; 142(2): 435-450.e10, 2018 08.
Article em En | MEDLINE | ID: mdl-29108965
BACKGROUND: Emerging studies suggest that enhanced glycolysis accompanies inflammatory responses. Virtually nothing is known about the relevance of glycolysis in patients with allergic asthma. OBJECTIVES: We sought to determine whether glycolysis is altered in patients with allergic asthma and to address its importance in the pathogenesis of allergic asthma. METHODS: We examined alterations in glycolysis in sputum samples from asthmatic patients and primary human nasal cells and used murine models of allergic asthma, as well as primary mouse tracheal epithelial cells, to evaluate the relevance of glycolysis. RESULTS: In a murine model of allergic asthma, glycolysis was induced in the lungs in an IL-1-dependent manner. Furthermore, administration of IL-1ß into the airways stimulated lactate production and expression of glycolytic enzymes, with notable expression of lactate dehydrogenase A occurring in the airway epithelium. Indeed, exposure of mouse tracheal epithelial cells to IL-1ß or IL-1α resulted in increased glycolytic flux, glucose use, expression of glycolysis genes, and lactate production. Enhanced glycolysis was required for IL-1ß- or IL-1α-mediated proinflammatory responses and the stimulatory effects of IL-1ß on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal epithelial cells. Inhibitor of κB kinase ε was downstream of HDM or IL-1ß and required for HDM-induced glycolysis and pathogenesis of allergic airways disease. Small interfering RNA ablation of lactate dehydrogenase A attenuated HDM-induced increases in lactate levels and attenuated HDM-induced disease. Primary nasal epithelial cells from asthmatic patients intrinsically produced more lactate compared with cells from healthy subjects. Lactate content was significantly higher in sputum supernatants from asthmatic patients, notably those with greater than 61% neutrophils. A positive correlation was observed between sputum lactate and IL-1ß levels, and lactate content correlated negatively with lung function. CONCLUSIONS: Collectively, these findings demonstrate that IL-1ß/inhibitory κB kinase ε signaling plays an important role in HDM-induced glycolysis and pathogenesis of allergic airways disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Escarro / Nariz / Mucosa Respiratória / Interleucina-1beta / Hipersensibilidade / Pulmão Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Escarro / Nariz / Mucosa Respiratória / Interleucina-1beta / Hipersensibilidade / Pulmão Idioma: En Ano de publicação: 2018 Tipo de documento: Article